摘要
2024版中国临床肿瘤学会(CSCO)乳腺癌诊疗指南基于国内外乳腺癌领域的研究进展、充分考虑药物的可及性、结合中国专家的意见更新,旨在制定更符合中国临床实际的诊疗规范。该文对新版指南在术前新辅助、术后辅助和晚期解救治疗更新要点解读。
The Guidelines for the Diagnosis and Treatment of Breast Cancer by Chinese Society of Clinical Oncology(CSCO)(2024 edition)were updated based on the latest advancements in breast cancer research globally,taking full account of drug accessibility,and incorporating the insights of Chinese experts.It aimed to develop diagnosis and treatment standards that are more in line with the clinical practice in China.This article summarizes the key updates of the new guidelines in neoadjuvant therapy before surgery,adjuvant therapy after surgery,and rescue therapy for advanced breast.
作者
邝美琼
刘真
江泽飞
KUANG Meiqiong;LIU Zhen;JIANG Zefei(Department of Oncology,The Fifth Medical Center of Chinese PLA General Hospital,Beijing 100071,China)
出处
《中国肿瘤外科杂志》
CAS
2024年第3期209-214,共6页
Chinese Journal of Surgical Oncology
基金
首都特色临床应用研究(Z181100001718215)。
